Growth hormones have been shown to have a variety of beneficial effects on the body, including improved health. It is sometimes important for subjects to take these medications in order to treat certain diseases or adverse effects of other medications. Tesamorelin, a peptide therapy for visceral fat, has demonstrated excellent outcomes in research subjects. You can find out more about Tesamorelin peptide and see whether it is a therapy choice that may help your subjects get well by reading on.
Tesamorelin Peptide In A Nutshell
There are exactly 44 amino acids in Tesamorelin, a synthetic GHRH peptide that mimics the human body’s production of GHRH. Tesamorelin, which was originally designed to reduce visceral fat in HIV-infected subjects with a disease known as lipodystrophy, was licensed by the FDA in 2010. One of the most cutting-edge male optimization studies, it has proved its capacity to improve quality of life in both physical as well as cognitive functioning.
By boosting IGF-1 quantities and connecting to GHRH receptors, tesamorelin stimulates pituitary GHRH synthesis at a pace similar to the body’s own naturally occurring rate. Triglyceride levels are reduced with Tesamorelin, which lowers your likelihood of heart disease. Atherosclerotic vascular disease may be prevented by lowering carotid intima medium thickness (cIMT) using this treatment. C-reactive protein levels and visceral adipose tissue (VAT) are also significantly reduced with Tesamorelin (CRP). Coronary heart disease and type 2 diabetes may be caused by excessive VAT. C-reactive proteins are generally a sign of an inflammatory illness when they are elevated.
Advantages for the Mind
Cognitive decline, including an increased risk for Alzheimer’s disease, has been linked to low levels of the human growth hormones HGH, GHRH, and IGF-1 in several studies. HGH production peaks throughout adolescence in order to aid growth and development in general. In contrast, HGH levels begin to fall around the age of 30 like other hormones like testosterone. Scientists now know that GHG, IGG-1, and GHRH all play important roles in the brain’s ability to operate properly.
Scientists at the University of Washington School of Medicine performed a 2011 study on 152 subjects, including healthy seniors and those with moderate cognitive impairment (MCI). For a period of twenty weeks, subjects were randomly assigned to receive either Tesamorelin or a placebo via self-injection. At an average of 117 percent, Tesamorelin injections raised IGF-1 levels in the circulation to the same levels as a healthy younger subject would normally reach. In both healthy subjects and those with MCI, the researchers found that Tesamorelin improved cognition and memory.
It is necessary for a doctor to provide Tesamorelin injections a prescription for medical cases. Few negative effects have been reported when the medication is provided by a skilled medical professional. However, there have been isolated reports of the following unusual adverse effects:
- Nighttime sweating
- Itching and a little rash
- Spasticity of muscles
- Retention of water
- Injection site discomfort
Subjects who have cancer or are receiving cancer treatment, pregnant females, or those who have had pituitary gland disorders should not be administered Tesamorelin. If you have a license and are interested in further researching this promising peptide, then you can buy Tesamorelin online, but for research purposes only.